Getting to the core of nuclear speckles
When the famous Spanish physician Santiago Ramón y Cajal looked through his microscope in 1910, he discovered irregular and “transparent lumps” that appeared throughout the nucleus of a neuron. What these nuclear speckles are all about is still largely unclear, even though the biological and medical sciences have experienced several revolutions since then. “Even though we know quite a bit about their function, we didn’t know how nuclear speckles originate, i.e. what their core consists of,” says Tuçe Akta from the Max Planck Institute for Molecular Genetics.
A Berlin team of scientists led by the Max Planck Research Group leader now identified the molecules that form the scaffold of nuclear speckles.The two proteins in question are SON and SRRM2, which are present in different variations throughout the entire animal kingdom. Both molecules are involved in the processing of RNA, which is produced when genes are transcribed. Without these proteins, the speckles dissolve.
Unlike other cell structures, speckles do not have a membrane envelope. They consist of an aggregation of molecules that can dynamically dissolve and reassemble, exhibiting the properties of solids as well as those of liquids. These “condensates” can be found throughout the cell. “Each cellular condensate has a protein that represents its nucleus — in the case of nuclear speckles, there are two,” says Akta.
Of red herrings and finding the right path
It is no coincidence that past attempts to identify the lowest common denominator of the mysterious structures have not been successful. “For 30 years scientists have been staining nuclear speckles with a reagent that they did not know very well,” says Akta. “We did not realize that we have been in the dark for decades.”
Since the early nineties, nuclear speckles have been visualised with a substance called SC35, which is an antibody that specifically attaches to certain sites in the speckles and can stain them with the help of pigments. Until recently, however, it was assumed that the antibody only recognizes the small protein SRSF2 — an assumption that now turned out to be wrong. “We wanted to use the antibody as a bait to fish for speckles in the cell,” says brahim Avar Ilk, the lead author of the study. “It was a great surprise to find the protein SRRM2, which was not the intended prey for our experiment.” It turned out that the antibody not only adheres to the already known SRSF2, but especially and particularly well to SRRM2.
Quest in the evolutionary family tree
While the sequence of SRRM2 varies widely in different animal species, the protein has a small section that has been preserved over hundreds of millions of years of evolution. Looking for similar proteins in the evolutionary family tree, the researchers also noticed the protein SON, which was considered by other research groups as a possible critical component of the speckles, too. “We had the idea that the combination of the two proteins could be the fundamental building block of the speckles,” says Ilk.
To test their hypothesis, the team grew human cells with the genes for either SRRM2 or SON switched off. This resulted in only spherical remnants of the speckles in the cell’s nuclei. Once the researchers knocked down both proteins simultaneously, all the speckles dissolved completely and associated proteins were found to be distributed throughout the cell nucleus. “We concluded that SRRM2 and SON must be the scaffold for nuclear speckles,” says Ilk. “Next, we will investigate how the two proteins bind to other molecules and how this process is controlled.”
Historical misinterpretation has consequences
But the results have even more, and perhaps far-reaching consequences. “Now that it is clear that SC35 binds to a different protein than assumed, previous research results on nuclear speckles must be carefully reevaluated,” says Akta.
The antibody SC35 has also been widely used in disease research, since the speckles have been implicated in several neurodegenerative conditions such as Huntington’s disease, spinocerebellar ataxia and dentatorubro-pallidoluysis atrophy. “There may be entirely new perspectives for research into these diseases,” says Akta.
Materials provided by Max-Planck-Gesellschaft. Note: Content may be edited for style and length.
Published at Mon, 30 Nov 2020 16:35:52 +0000